Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
After finishing at $0.12 in the prior trading day, AIM ImmunoTech Inc (AMEX: AIM) closed at $0.12, down -3.33%. In other words, the price has decreased by -$3.33 from its previous closing price. On the day, 0.51 million shares were traded. AIM stock price reached its highest trading level at $0.13 during the session, while it also had its lowest trading level at $0.1158.
Ratios:
Our goal is to gain a better understanding of AIM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.75. In the meantime, Its Debt-to-Equity ratio is 1.17 whereas as Long-Term Debt/Eq ratio is at 0.20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’25 when Equels Thomas K bought 50,000 shares for $0.13 per share. The transaction valued at 6,730 led to the insider holds 1,858,029 shares of the business.
Equels Thomas K bought 44,000 shares of AIM for $5,060 on Mar 04 ’25. The CEO & President now owns 1,808,029 shares after completing the transaction at $0.12 per share. On Mar 04 ’25, another insider, Equels Thomas K, who serves as the CEO & President of the company, bought 83,334 shares for $0.12 each. As a result, the insider paid 10,000 and bolstered with 1,764,029 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AIM now has a Market Capitalization of 7975499 and an Enterprise Value of 3588947. For the stock, the TTM Price-to-Sale (P/S) ratio is 42.00 while its Price-to-Book (P/B) ratio in mrq is 2.34. Its current Enterprise Value per Revenue stands at 18.889 whereas that against EBITDA is -0.13.
Stock Price History:
The Beta on a monthly basis for AIM is 0.77, which has changed by -0.68421054 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, AIM has reached a high of $0.62, while it has fallen to a 52-week low of $0.11. The 50-Day Moving Average of the stock is -31.25%, while the 200-Day Moving Average is calculated to be -56.62%.
Shares Statistics:
The stock has traded on average 1.10M shares per day over the past 3-months and 805420 shares per day over the last 10 days, according to various share statistics. A total of 68.75M shares are outstanding, with a floating share count of 60.76M. Insiders hold about 11.63% of the company’s shares, while institutions hold 6.76% stake in the company. Shares short for AIM as of 1740700800 were 3285045 with a Short Ratio of 3.00, compared to 1738281600 on 914816. Therefore, it implies a Short% of Shares Outstanding of 3285045 and a Short% of Float of 5.19.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
